PAEDIATRICS - 1 Flashcards

(225 cards)

1
Q

Define macule

A

Small, flat, non-palpable change in skin colour (0.5-1cm diameter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define papule

A

Small, solid, raised lesion, usually dome shaped (0.5-1cm diameter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define vesicle

A

Small blister that contains clear fluid (0.5-1cm diameter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define pustule

A

Visible collection of pus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define bulla

A

Large blister containing clear fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of maculopapular rash - viral

A
HHV-6
HHV-7 (roseola infantum) <2 years old
Enterovirus
Parvovirus
Measles
Rubella
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of maculopapular rash - bacterial

A

Scarlet fever (group A strep)
Rheumatic fever
Salmonella typhi (typhoid)
Lyme disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of maculopapular rash - other

A

Kawasaki disease

Systemic onset juvenile idiopathic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes of vesicular, bullous and pustular rashes - viral

A

VZV
HSV
Coxsackie virus - hand, foot and mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of vesicular, bullous and pustular rashes - bacterial

A

Impetigo - crusting
Boils
Staphylococcal bullous impetigo
Staphylococcal scalded skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of vesicular, bullous and pustular rashes - other

A

Erythema multiform
Stevens-Johnson syndrome
Toxic epidermal necrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of petechial and purpuric rashes - bacterial

A

Meningococcal
Other bacterial sepsis
Infective endocarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of petechial and purpuric rashes - viral

A

Enteroviruses

Adenoviruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of petechial and purpuric rashes - other

A

Henoch-Schonlein purpura
Thrombocytopenia
Vasculitis
Malaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Beginning of infectious period relative to appearance of rash

A

• Infectious period begins ½ day before the RASH appears

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Signs of a rash that indicate the person is no longer infectious

A

Rash has cleared up/ lesions have dried out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Types of human herpesvirus

A
  1. ) Herpes simplex virus 1 (HSV-1)
  2. ) Herpes simplex virus 2 (HSV-2)
  3. ) Varicella zoster virus (VZV)
  4. ) Cytomegalovirus (CMV)
  5. ) Epstein-Barr virus (EBV)
  6. ) Human herpesvirus 6 (HHV-6)
  7. ) Human herpes virus 7 (HHV-7)
  8. ) Human herpes virus 8 (Kaposi sarcoma in HIV +’ve)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Virus and condition associated with Kaposi sarcoma

A

Human herpes virus 8

HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Varicella zoster virus (VZV) timeline of events

A

VZV –> chickenpox (varicella zoster) –> VZV remains latent in dorsal root ganglia –> reactivation of VZV –> shingles (herpes zoster)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Herpes Simplex Virus (HSV): type of organism

A

DNA herpesvirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

HSV type 1 - clinical feature

A

Cold sores

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

HSV type 2 - clinical feature

A

Genital herpes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HSV: transmission

A
  • Enters through mucous membranes or skin

* Site of primary infection –> local mucosal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HSV: clinical features

A
  • Lip and skin lesions
  • Genital lesions
  • HSV infections are very common and mostly asymptomatic in children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
HSV: treatment
Aciclovir (viral DNA polymerase inhibitor)
26
HSV: complications
1. ) Gingivostomatitis 2. ) Eczema herpeticum 3. ) Herpetic whitlows 4. ) Blepharitis/ conjunctivitis
27
Gingivostomatitis: clinical presentation
* Vesicular lesions on lips, gums, tongue and hard palate --> ulceration and bleeding * Fever + miserable child * Eating and drinking are painful --> dehydration
28
Gingivostomatitis: treatment
Treat symptoms + IV Aciclovir ( if severe)
29
Eczema herpeticum: clinical presentation
* Widespread vesicular lesions * Develop on eczematous skin * Can lead to septicaemia
30
Herpetic whitlows: clinical presentation
* Painful, erythematous, oedematous white pustules on site of broken skin * Typically, on fingers
31
Herpetic whitlows: spread
• Spread from gingivostomatitis and infected adults kissing children’s fingers
32
Blepharitis/ conjunctivitis: clinical presentation
Herpetic lesions near or involving eye | --> Requires URGENT ophthalmic assessment (slit lamp assessment)
33
Chicken pox (VZV): transmission
* Respiratory droplets * Highly infectious * Incubation period around 2 weeks
34
Chicken pox (VZV): pathology
Papules --> vesicles --> pustules --> crusts
35
Chicken pox (VZV): clinical presentation
* 50-500 lesions on head and trunk * Appear as crops of papules, vesicles and pustules * Itchy * Scratching --> permanent, depigmented scar
36
Chicken pox (VZV): complications
* Bacterial superinfection (staph, strep) * CNS (cerebellitis, encephalitis, meningitis) * Immunocompromised (pneumonitis, disseminated infection, DIC)
37
Chicken pox (VZV): treatment
* Usually self-limiting so NO treatment required | * For immunocompromised patients --> IV aciclovir or HZV immunoglobulin
38
Shingles (VZV): pathology
Reactivation of latent VZV --> vesicular eruption
39
Shingles (VZV): clinical presentation
* Lesions appear in a dermatomal distribution of sensory nerves * Unilateral - sharp cut-off at anterior and posterior midlines * Commonly in thoracic region * Begins as a crop of red papules --> vesicles/ pustules --> crusts * Fever * Neuralgic pain
40
Shingles (VZV): treatment
1. ) Oral aciclovir 800mg 5 times daily for 7 days 2. ) Analgesia 3. ) Protective ointment applied to rash 4. ) Oral antibiotics for secondary infection
41
Infectious mononucleosis (EBV): pathology
EBV --> B lymphocytes + epithelial cells of oropharynx
42
Infectious mononucleosis (EBV): transmission
• Oral contact
43
Infectious mononucleosis (EBV): clinical presentation
* Fever * Malaise, fatigue * Tonsillitis/ pharyngitis * Lymphadenopathy * Petechiae * Splenomegaly * Hepatomegaly * Maculopapular rash * Jaundice
44
Infectious mononucleosis (EBV): investigations
1. ) Atypical lymphocytes - Numerous large T cells seen on blood film 2. ) Positive monospot test - Tests for presence of heterophile antibodies (these are a/w EBV) 3. ) Seroconversion antibodies - Viral capsid antigen antibodies (VCA) - IgG and IgM - EB nuclear antigen antibodies (EBNA)
45
Infectious mononucleosis (EBV): treatment
1. ) Self-limiting 2. ) For secondary bacterial tonsillitis --> penicillin - DO NOT given amoxicillin --> maculopapular rash in those infected with EBV
46
Cytomegalovirus (CMV): transmission
* Saliva * Genital secretions * Breast milk
47
Cytomegalovirus (CMV): clinical presentation
``` • Causes mild or subclinical infection in normal paediatric and adult hosts – presents as mononucleosis-like: - Mild pharyngitis - Mild lymphadenopathy • In the immunocompromised: - Retinitis - Pneumonitis - Bone marrow failure - Encephalitis - Hepatitis - Oesophagitis ```
48
Cytomegalovirus (CMV): investigations
1. ) Blood film - Atypical lymphocytes 2. ) Negative monospot test 3. ) CMV IgM raised
49
Cytomegalovirus (CMV): treatment
1.) IV ganciclovir
50
Human herpes virus 6 and 7 (HHV 6/7): clinical presentation
* Fever + malaise * Exanthema subitem (roseola infantum) * Generalised macular rash
51
Human parvovirus B19: clinical presentation
``` Slapped cheek syndrome • Erythema infectiosum/ slapped cheek - Fever - Malaise - Headache - Myalgia - Slapped-cheek rash - Maculopapular ‘lace’ like rash on trunk and limbs ```
52
Human parvovirus B19: transmission
* Common during spring * Respiratory secretions * Vertical transmission
53
Enterovirus: transmission
* Faecal-oral * Respiratory droplets * Outbreaks in summer and autumn
54
Enterovirus: resulting infective conditions
1. ) Hand, foot and mouth disease 2. ) Herpangina 3. ) Pleurodynia (Bornholm disease)
55
Hand, foot and mouth disease: clinical presentation
* Painful vesicular lesions on hands, feet, mouth and tongue | * Mild systemic features
56
Hand, foot and mouth disease: treatment
• Disease is self-limiting and subsides within a few days
57
Herpangina: clinical presentation
* Vesicular and ulcerated lesions on soft palate and uvula | * Causes anorexia, pain on swallowing and fever
58
Herpangina: treatment
• IV fluids and analgesia required in severe cases
59
Pleurodynia (Bornholm disease): clinical presentation
* Pleuritic chest pain * Muscle tenderness * Self-limiting within a few days
60
Measles: causative organism
Rubeola virus
61
Measles: immunisation
MMR vaccine
62
Measles: transmission
• Droplet spread, highly infectious
63
Measles: clinical presentation
``` • Increasing temperature • Cough • Conjunctivitis and coryza • Koplik spots (white spots on buccal mucosa) • Rash - Spreads downwards, from behind ears --> whole body - Initially maculopapular - Becomes blotchy and confluent ```
64
Measles: complications
* Pneumonia * Febrile seizures * Diarrhoea
65
Measles: treatment
1. ) Supportive 2. ) For immunocompromised patients --> Ribavirin (antiviral) may be used 3. ) Vitamin A given in low-income countries
66
Mumps: causative organism
Mumps virus
67
Mumps: transmission
* Respiratory droplets * Common in winter and spring months * Virus gains access to parotid glands * Incubation period is 15 days – 24 days
68
Mumps: clinical features
* Fever, malaise and parotitis | * Bilateral parotid involvement
69
Mumps: investigations
1. ) Clinical diagnose | 2. ) Raised amylase levels (due to parotid inflammation)
70
Rubella: causative organism
Rubella virus
71
Rubella: transmission
* Occurs in winter and spring * Can cause SEVERE damage to FETUS * Incubation period is 15-20 days * Respiratory droplets
72
Rubella: clinical presentation
* Low grade fever * Maculopapular rash * Spreads centrifugally to cover the whole body * Prominent lymphadenopathy
73
Rubella: treatment
* MMR to prevent * Usually self-limiting * No effective antiviral treatment available
74
Types of bacterial infections in children
1.) Meningococcal 2.) Pneumococcal 3.) Staphylococcal and group A streptococcal • Impetigo • Boils • Periorbital cellulitis • Staphylococcal scalded skin syndrome
75
Define pneumococcal
Infection caused by streptococcus pneumoniae or pneumococcus
76
Pneumococcal infection: transmission
* Streptococcus pneumoniae is carried in nasopharynx of healthy children * Asymptomatic carriage is prevalent among young children * Transmitted --> respiratory droplets
77
Pneumococcal infection: conditions caused by this bacteria
* Pharyngitis * Otitis media * Conjunctivitis * Sinusitis * Invasive disease (pneumonia, bacterial sepsis, meningitis)
78
Pneumococcal infection: vaccination
• Pneumococcal conjugate vaccine (PCV) is given to babies at 12 weeks and 1 year --> brand name = Prevenar 13 (covers 13 different serotypes) • Pneumococcal polysaccharide vaccine (PPV) is given to people >65
79
Pneumococcal infection: vulnerable people
• Those with hyposplenism (e.g. sickle cell disease) or asplenism are given daily prophylactic penicillin
80
Define impetigo
Highly infectious skin lesions caused by staphylococcus or group A streptococcus
81
Impetigo: pathophysiology
* Infection usually results from direct invasion of organism * These organism can also release toxins --> these toxins act as superantigens --> superantigens bind to T-cells and stimulate MASSIVE T-cell proliferation + cytokine release
82
Impetigo: epidemiology
* Commonly occurs in infants and young children | * More common in children with pre-existing skin disease e.g. atopic eczema
83
Impetigo: clinical presentation
* Localised * Highly contagious * Staphylococcal or streptococcal skin infection * Lesions usually on face, neck and hands * Begin as erythematous macules * Progresses into vesicles/ pustules/ bullae * When these rupture --> honey-coloured crusted lesions
84
Impetigo: treatment
1. ) Topical antibiotics e.g. mupirocin (mild cases) 2. ) Narrow spectrum antibiotics e.g. flucloxacillin (severe cases) 3. ) Broad spectrum antibiotics e.g. co-amoxiclav (taste better --> better adherence, but not as effective) 4. ) Affected children should NOT go to nursey or school until LESIONS HAVE DRIED OUT
85
Define boils
Infections of hair follicles or sweat glands, caused by staphylococcus aureus
86
Boils: treatment
Systemic antibiotics + surgical incision (occasionally)
87
Periorbital cellulitis: clinical presentation
* Fever * Erythema, oedema and tenderness of eyelid * Unilateral * Proptosis * Painful or limited ocular movement * May have reduced visual acuity
88
Periorbital cellulitis: management
1. ) IV ceftriaxone | 2. ) CT or MRI head (to assess posterior spread of infection)
89
Periorbital cellulitis: complications
* Abscess * Meningitis * Cavernous sinus thrombosis
90
Scaled skin syndrome: causative organism
Staphylococcal TOXIN
91
Scaled skin syndrome: pathology
Staphylococcal toxin --> causes separation of the epidermal layer
92
Scaled skin syndrome: clinical presentation
* Fever, malaise * Purulent, crusting and localised infection * Around eyes, nose and mouth * Widespread erythema * Tenderness of skin * Areas of epidermis separate on gentle pressure (Nikolsky sign)
93
Define Nikolsky sign
Areas of epidermis separate on gentle pressure --> characteristic of scaled skin syndrome
94
Scaled skin syndrome: treatment
1. ) IV flucloxacillin 2. ) Analgesia 3. ) Fluid balance monitoring
95
Childhood immunisation schedule: 8 weeks
``` 6-in-1 vaccine (1st done) Rotavirus vaccine (1st dose) MenB (1st dose) ```
96
Childhood immunisation schedule: 12 weeks
``` 6-in-1 vaccine (2nd dose) Pneumococcal (PCV) vaccine (1st dose) Rotavirus vaccine (2nd dose) ```
97
Childhood immunisation schedule: 16 weeks
6-in-1 vaccine (3rd dose) | MenB (2nd dose)
98
Childhood immunisation schedule: 1 year
Hib/MenC (1st dose) MMR (1st dose) PCV (2nd dose) MenB (3rd dose)
99
Childhood immunisation schedule: 2-10 years
Flu vaccine annually
100
Childhood immunisation schedule: 3 years and 4 months
MMR (2nd dose) | 4-in-1 pre-school booster
101
Childhood immunisation schedule: 12-13 years
HPV vaccine
102
Childhood immunisation schedule: 14 years
3-in-1 teenage booster | MenACWY
103
6-in-1 vaccine
1. ) Diphtheria 2. ) Hepatitis B 3. ) Haemophilus influenzae type b (Hib) 4. ) Polio 5. ) Tetanus 6. ) Whooping cough (pertussis)
104
Barriers to good vaccination coverage
* Lack of parental education * Low income * Poor access to health facilities * Traditional beliefs
105
Ethical dilemmas surrounding immunisation
* Difficulties securing transportation to a health care provider * Inability to pay or vaccination * Mistakenly believe that vaccinations are for others and not for their own children * Believe that a few nonvaccinating parents will have no impact on an outbreak likelihood or management * Mandatory vaccines for school entry in USA
106
Define Kawasaki disease
Systemic vasculitis
107
Kawasaki disease: potential complications
Coronary artery aneurysms
108
Kawasaki disease: diagnostic criteria
1.) Fever (>38.5) present for at least 5 days 2.) PLUS 4/5 of: • Bilateral congestion of the ocular conjunctivae: non-purulent (not discharging pus) • Changes of lips + oral cavity with at least one of: - Dryness - Erythema - Fissuring of lips - Strawberry tongue - Diffuse erythema of oral and pharyngeal mucosa without discrete lesions • Changes of extremities with at least one of: - Erythema of palms and soles - Indurative oedema - Peeling of fingers and toes • Polymorphous exanthem (rash) • Non-suppurative cervical lymphadenopathy >1.5cm N.B misery is a VERY common feature too
109
Kawasaki disease: other clinical features that may be present
• Inflammation of BCG scar
110
Kawasaki disease: investigations
1. ) FBC - Raised WBC - Raised neutrophils 2. ) Platelets - raised 3. ) ESR/ CRP - raised 4. ) Echocardiogram - Performed at 6 weeks - To check for aneurysms
111
Kawasaki disease: treatment
1.) IV immunoglobulin - Give within 10 days - Lowers risk of coronary artery aneurysms 2.) Aspirin - To reduce risk of thrombosis For persistent inflammation: 3.) Corticosteroid 4.) Infliximab (TNF-alpha monoclonal antibody) 5.) Cyclosporin
112
Kawasaki disease: mortality
• 1-2% due to myocardial ischaemia or MI
113
Measuring temperature: neonate <4 weeks
Electronic thermometer in axilla
114
Measuring temperature: 4 weeks-5 years
Electronic/ chemical dot thermometer in axilla or infrared tympanic thermometer
115
Define fever
>37.5 Degrees Celsius
116
Investigations for febrile infants <3 months
1. ) Septic screen | 2. ) Broad-spectrum antibiotics
117
Components of a septic screen
1. ) Blood culture 2. ) FBC including differential WCC 3. ) Acute phase reactant (e.g. CRP) 4. ) Urine sample
118
Other investigations to consider in a febrile child
5. ) Chest x-ray 6. ) LP 7. ) Rapid antigen screen on blood/ CSF/ urine 8. ) Meningococcal and pneumococcal polymerase chain reaction (PCR) on blood/ CSF 9. ) PCR for viruses in CSF (e.g. HSV and enteroviruses)
119
Aetiology of mortality in children <5 years
1. ) Infection (40%) 2. ) Prematurity (18%) 3. ) Congenital anomalies (13%) 4. ) Intrapartum-related complications (11%)
120
Risk factors for infection
* Illness of other family members * Illness prevalent in community * Lack of immunization * Recent travel abroad (malaria, typhoid, viral hepatitis) * Contact with animals (brucellosis, Q fever, haemolytic uremic syndrome – E.coli) * Secondary immunodeficiency (nephrotic syndrome, splenectomy)
121
Red flags in febrile infants
* Fever >38 degrees and <3 months old * Fever >39 degrees and 3-6 months old * Colour – pale, mottled or cyanosed * Reduced consciousness * Neck stiffness * Bulging fontanelle * Status epilepticus * Focal neurological signs * Seizures * Significant respiratory distress * Bile-stained vomiting * Severe dehydration/ shock
122
Most common cause of fever in a child
URTI
123
Cushing's triad
Bradycardia, hypertension and abnormal pattern of breathing
124
Define opisthotonos
Hyperextension of head and back (think tetanus image)
125
Management of mild fever
1. ) Manage at home 2. ) Regular review by parents 3. ) Provide clear instructions e.g. safety net for red flags 4. ) Give paracetamol or ibuprofen for fever
126
Management of significant fever with no focus of infection
1. ) Hospital admission 2. ) Investigations and observation or treatment 3. ) Septic screen 4. ) Parenteral antibiotics administered - Cefotaxime + ampicillin for <1-month-old - Ceftriaxone for >1-month-old - Aciclovir if HSV encephalitis suspected 5. ) Give paracetamol or ibuprofen for fever
127
Infection treated with ampicillin
Listeria
128
Types of serious life-threatening infections
1. ) Sepsis 2. ) Bacterial meningitis 3. ) Viral meningitis 4. ) Encephalitis 5. ) Toxic shock syndrome 6. ) Necrotizing fasciitis/ cellulitis
129
Sepsis: example of pathophysiology
Bacteria --> focal infection --> proliferate in bloodstream --> host response causes release of inflammatory cytokines --> activation of endothelial cells --> sepsis
130
Define septicaemia
Causative microorganism enters blood stream and cause blood poisoning
131
Define sepsis
Overwhelming and life-threatening response, triggered by septicaemia or viral infection
132
Most common organisms that cause sepsis
1. ) Staphylococcus (coagulase negative) - CoNS 2. ) Staphylococcus aureus 3. ) Non-pyogenic streptococci 4. ) Streptococcus pneumonia (pneumococcus) 5. ) Neisseria meningitidis (meningococcus) 6. ) Escherichia coli 7. ) Haemophilus influenzae
133
Most common causative organism of sepsis in neonates
Group B streptococcus and E.coli
134
Clinical features of septicaemia
* Fever * Poor feeding * Miserable, irritable, lethargic * History of focal infection (meningitis, osteomyelitis, gastroenteritis, cellulitis) * Predisposing conditions (sickle cell disease, immunodeficiency) * Tachycardia, tachypnoea, hypotension * Purpuric rash (meningococcal septicaemia) * Shock * Multiorgan failure
135
Management of sepsis
1. ) Admission to paediatric intensive care if infant has multiorgan failure, otherwise admit to paediatric ward 2. ) Antibiotic therapy 3. ) Fluid resuscitation 4. ) Mechanical ventilation may be required 5. ) Inotropes for hypotension 6. ) If bleeding occurs, administer: - Fresh frozen plasma - Cryoprecipitate - Platelet transfusion
136
Pathophysiology of hypovolaemia in sepsis
Vasoactive mediators released (NO, leukotrienes, prostaglandins) --> loss of intravascular proteins and fluid --> capillary leak --> circulating plasma moves to interstitial fluid Capillary leak in lungs --> pulmonary oedema --> respiratory failure
137
Pathophysiology of myocardial dysfunction in sepsis
Inflammatory cytokines and circulating toxins --> depress myocardial contractility
138
Pathophysiology of DIC in sepsis
Abnormal blood clotting --> widespread microvascular thrombosis --> consumption of clotting factors
139
Define meningitis
Inflammation of meninges, confirmed by presence of WBC in CSF
140
Types of meningitis
Viral, bacterial, TB meningitis, non-infectious meningitis (malignancy, autoimmune)
141
Pathophysiology of bacterial meningitis
• Bacteraemia --> bacterial infection of the meninges • Host response to the infection causes more damage than the actual causative organism • Host response: - Release of inflammatory mediators (histamine, prostaglandins, leukotrienes, NO) - Activation of leucocytes - Endothelial damage • Leads to cerebral oedema --> raised ICP --> decreased cerebral blood low • Cerebral cortical infarction • Fibrin deposits --> block resorption of CSF by arachnoid villi --> hydrocephalus
142
Bacterial meningitis most common causative organisms - neonates
Group B streptococcus E coli Listeria monocytogenes
143
Bacterial meningitis most common causative organisms - 1 month-6years
Neisseria meningitides Streptococcus pneumonias Haemophilus influenza
144
Bacterial meningitis most common causative organisms - >6 years
Neisseria meningitides | Streptococcus pneumonias
145
Symptoms of meningitis/ encephalitis
* Fever * Headache * Photophobia * Lethargy * Poor feeding * Vomiting * Irritability * Hypotonia * Drowsiness * Loss of consciousness * Seizures
146
Signs of meningitis/ encephalitis
* Fever * Purpuric rash (meningococcal disease) * Neck stiffness * Bulging fontanelle * Opisthotonos * Positive Brudzinski sign * Positive Kernig sign * Signs of shock (pale, cold, sweating, rapid shallow breathing, weakness) * Focal neurological signs * Altered conscious level * Papilloedema (rare)
147
Investigations for suspected meningitis/ encephalitis
1. ) FBC with differential WCC 2. ) Blood glucose and blood gas (acidosis) 3. ) Coagulation screen 4. ) CRP 5. ) U&E’s 6. ) LFT’s 7. ) Culture of blood, throat swab, urine and stool for bacteria 8. ) Throat swab, nasopharyngeal aspirate, conjunctival swab, stool sample for viral PCR 9. ) Rapid antigen test for meningitis organisms (blood, CSF or urine) 10. ) LP for CSF unless CI 11. ) If TB suspected --> CXR, Mantoux test ± interferon-gamma release assay, gastric aspirates or sputum for MC&S 12. ) Consider CT/MRI brain and EEG
148
Contraindications for lumbar puncture
* Cardiorespiratory instability * Focal neurological sings * Signs of raised ICP (coma, high BP, low HR, papilloedema) * Coagulopathy * Thrombocytopenia * Local infection at site of LP * If it causes delay in starting antibiotics
149
CSF results: normal
Clear 0-5/mm^3 WBC 0.15-0.4g/L protein >50% of blood is glucose
150
CSF results: bacterial meningitis
Turbid Increased polymorphs Increased protein Decreased glucose
151
CSF results: viral meningitis
Clear Increased lymphocytes Normal or increased protein Normal or decreased glucose
152
CSF results: TB meningitis
Turbid/ clear/ viscous Increased lymphocytes HUGE Increase protein HUGE decrease in glucose
153
CSF results: encephalitis
Clear Normal or increased lymphocytes Normal or increased protein Normal or reduced glucose
154
Management of bacterial meningitis
1.) Antibiotic therapy, depending on causative organism  Ceftriaxone (3rd generation cephalosporin) covers the most common bacterial causes so can be started before results come back 2.) Fluid resuscitation
155
Cerebral complications of bacterial meningitis
``` • Hearing impairment - Inflammatory damage to cochlear hair cells • Local vasculitis - Can lead to CN palsies • Local cerebral infarction - Can lead to seizures • Subdural effusion - a/w Haemophilus influenzae B and pneumococcal meningitis - Most resolve spontaneously • Hydrocephalus due to: - Impaired resorption of CSF - Blockage of cerebral aqueduct - Blockage of ventricular outlets by fibrin • Cerebral abscess ```
156
Prophylaxis of bacterial meningitis
1. ) Rifampicin or ciprofloxacin is given to all household contacts for meningococcal meningitis or Hib infection 2. ) Meningococcal group C vaccine given to household contacts for group C meningococcal meningitis infection
157
Viral meningitis: causative organisms
1. ) Enteroviruses 2. ) Epstein-Barr virus (EBV) 3. ) Adenoviruses 4. ) Mumps
158
Viral meningitis: investigations
1. ) Culture or PCR of CSF, stool, urine, nasopharyngeal aspirate and throat swabs 2. ) Viral serology
159
Viral or bacterial meningitis worse presentation?
Bacterial
160
Define encephalitis
Inflammation of the brain
161
Encephalitis: epidemiology
* Mortality rate for untreated encephalitis is >70% | * Survivors of untreated encephalitis usually have severe neurological sequelae
162
Causes of encephalitis
* Herpes Simplex Virus (HSV - neurotoxic) infection of brain * Postinfectious encephalopathy e.g. following chickenpox, a delayed brain swelling can occur * Slow virus infection e.g. HIV or SSPE (subacute sclerosing panencephalitis) following measles
163
Most common causative organisms of encephalitis
1. ) Enterovirus 2. ) Respiratory virus (Hib) 3. ) HSV (herpes simplex virus) 4. ) VZV (varicella zoster virus) 5. ) HHV-6 (human herpesvirus) 6. ) Microplasma 7. ) B. burgdorferi (Lyme disease) 8. ) Bartonella henselae (cat scratch disease)
164
Investigations to detect HSV
* PCR of CSF * EEG (electroencephalogram) * CT/ MRI (gross atrophy in temporoparietal regions from loss of neural tissue) * HSV antibody production in the CSF
165
Encephalitis: treatment
1. ) High-dose IV Aciclovir | - -> Aciclovir treatment continued for 3 weeks
166
Toxic shock syndrome: clinical presentation
1. ) Fever >39 degrees 2. ) Hypotension 3. ) Diffuse erythematous, macular rash
167
Toxic shock syndrome: causative organism
Toxin-producing staphylococcus aureus and Group A streptococci
168
Toxic shock syndrome: pathophysiology
1. ) Toxin-producing organism 2. ) Toxin released from infection at any site 3. ) Toxin acts as a superantigen 4. ) Causes organ dysfunction
169
Toxic shock syndrome: complications
* Mucositis (conjunctivae, oral mucosa, genital mucosa) * GI dysfunction (vomiting/ diarrhoea) * Renal impairment * Liver impairment * Clotting abnormalities * Thrombocytopenia * Altered consciousness
170
Toxic shock syndrome: management
1.) Intensive care support to manage shock 2.) Surgical debridement of infected areas 3.) Ceftriaxone + clindamycin  clindamycin acts on bacterial ribosome and switches off toxin production 4.) IV Ig to neutralize circulating toxin
171
Pathology of PVL toxin
* PVL (Panton-Valentine leucocidin) is produced by <2% of staphylococcus aureus strains * It causes recurrent skin and soft-tissue infections * Can also cause necrotizing fasciitis/ necrotizing haemorrhagic pneumonia --> both have high mortality rate * Frequently results in VTE
172
Define necrotising fasciitis/ cellulitis
• Rare, severe subcutaneous infection
173
Necrotising fasciitis/ cellulitis: clinical presentation
* Often involves fascia and muscle * Area enlarges rapidly --> poorly perfused necrotic areas * Severe, painful and systemic illness requiring intensive care
174
Necrotising fasciitis/ cellulitis: causative organisms
Staphylococcus aureus or group A streptococcus
175
Necrotising fasciitis/ cellulitis: management
• Surgical intervention + debridement of necrotic tissue + IV antibiotics + IVIg
176
Lyme disease: causative organism
Spirochaete B burgdorferi
177
Lyme disease: transmission
Transmitted by hard ticks Hosts include deer and mouse More common in summer
178
Lyme disease: incubation period
4-20 days
179
Lyme disease: clinical presentation (acute stages)
- erythematous macule at site of tick bite - enlarges to form erythema migrant (painless red expanding lesion with a bright red outer spreading edge) - fever - headache - malaise - myalgia - lymphadenopathy - CN palsies
180
Lyme disease: clinical presentation (chronic stages)
- Meningoencephalitis - Cranial and peripheral neuropathies - Myocarditis - Heart block - Monoarthritis - Oligoarthritis
181
Lyme disease: investigations
1. ) Clinical diagnosis | 2. ) Serology
182
Lyme disease: treatment
1. ) Doxycycline (>12 years) 2. ) Amoxicillin (<12 years) 3. ) IV ceftriaxone (carditis or neurological disease
183
Classification of immunodeficiency
1. ) Primary | 2. ) Secondary (more common)
184
Primary immunodeficiency: inheritance
X - linked or autosomal recessive | FH of consanguinity or unexplained death
185
Clinical features of immunodeficiency
Severe, prolonged, unusual or recurrent infection
186
Primary immunodeficiency: examples of T cell defects conditions
``` Severe combined immunodeficiency (SCID) HIV infection Wiskott-Aldrich syndrome DiGeorge syndrome Duncan disease Ataxia telangiectasia ```
187
T cell defect: clinical presentation
Severe or unusual viral and fungal infections
188
B cell defect: clinical presentation
Severe bacterial infections
189
Neutrophil defect: clinical presentation
Recurrent bacterial infections
190
Leucocyte function defect: clinical presentation
Delayed separation of umbilical cord | Delayed wound healing
191
Complement defect: clinical presentation
Recurrent bacterial infections | SLE-like illness
192
Primary immunodeficiency: examples of B cell defects conditions
X-linked agammaglobulinaemia CVID (common variable immune deficiency) Hyper IgM syndrome Selective IgA deficiency
193
Primary immunodeficiency: examples of neutrophil defect conditions
Chronic granulomatous disease
194
Primary immunodeficiency: examples of leucocyte function defect conditions
Leucocyte adhesion deficiency (LAD)
195
Define Wiskott-Aldrich syndrome
Triad of immunodeficiency, thrombocytopenia and eczema
196
Primary immunodeficiency: investigations
1. ) T cells 2. ) B cells (antibodies) 3. ) Neutrophils 4. ) Complement/ mannose-binding lectin
197
Management of immunodeficiency
1. ) Antimicrobial prophylaxis 2. ) Antibiotic treatment 3. ) Screening for end-organ disease 4. ) Ig replacement therapy 5. ) Bone marrow transplant
198
Define hypersensitivity
Objectively reproducible symptoms or signs following exposure to a defined stimulus (e.g. food, drug, pollen) at a dose that is usually tolerated by most people
199
Define allergy
A hypersensitivity reaction initiated by specific immunological mechanisms.
200
Classification of allergy
``` IgE mediated (e.g. peanut allergy) Non-IgE mediated (e.g. coeliac disease) ```
201
Define atopy
Personal or familial tendency to produce IgE antibodies in response to ordinary exposures to potential allergens, usually proteins. Strongly a/w asthma, allergic rhinitis and conjunctivitis, eczema and food allergy.
202
Define anaphylaxis
Serious allergic reaction Bronchial, laryngeal and CV involvement Rapid onset and can lead to death
203
Mechanisms of allergic disease
The developing immune system must be sensitised to an allergen before an allergic immune response develops.
204
Most common stimuli associated with allergies
Inhalant allergens (house-dust mite, plant pollens, pet dander and moulds) Ingestant allergens (cow's milk, nuts, soya, egg, wheat, seeds, legumes, seafood and fruits) Insect stings/ bites, drugs and natural rubber latex
205
IgE mediated allergic reactions - clinical course
Early phase (minutes) - Caused by release of histamine and other mast cell mediators - Causes urticaria, angiodema, sneezing, vomiting, bronchospasm +/or cardiovascular shock Late phase (4-6 hours) - Nasal congestion - Cough - Bronchospasm
206
The hygiene hypothesis
Allergy and autoimmune disease is associated with: - Small family size - Low exposure to parasites - Few infections - High antibiotic exposure - Low farming exposure - -> Low microbial exposure
207
Define the allergic march
Presence of eczema or food allergy in infancy is predictive of asthma and allergic rhinitis in later life
208
Define food intolerance
Non-immunological hypersensitivity reaction to a specific food
209
Most common food allergies in infants
Milk Egg Peanut
210
Most common food allergies in children
Peanut Trent Fish Shellfish
211
Define pollen food allergy syndrome
A child previously not allergic to apples, develops an allergy to birch trees, and subsequently develops an allergy to apples due to the fact that the apple and birch pollen are similar proteins Leads to itchy mouth with NO systemic symptoms
212
Clinical features of an acute allergic reaction - mild
Urticaria Itchy skin Facial swelling
213
Clinical features of an acute allergic reaction - severe
``` Wheeze Stridor Abdominal pain Vomiting Diarrhoea Shock Collapse ```
214
Management of food allergies
1. ) AVOIDANCE 2. ) Written management plan for acute attack - non-sedating antihistamines - epinephrine (EpiPen)
215
Allergic rhinitis and conjunctivitis: treatment
1. ) 2nd generation non-sedating antihistamines 2. ) Topical or nasal corticosteroid 3. ) Cromoglycate eye drops 4. ) Leukotriene receptor antagonists e.g. montelukast
216
Eczema: general clinical presentation
• Inflamed red, dry thickened (lichenified) patches • Flexural • Infected – weepy, crusted Extremely itchy
217
Eczema: distribution seen in infants
Cheeks
218
Eczema: distribution seen in toddlers
``` Wrists Elbows Ankles Knees Genitalia ```
219
Eczema: distribution seen in older children
``` Flexural surfaces Eyelids Ears Neck Scalp ```
220
Eczema: variants
* Discoid eczema (circular, well-defined patches) * Eczema herpeticum * Hand eczema * Pompholyx eczema (water blisters on palms and soles, very itchy)
221
Eczema: assessment tool
``` EASI score (eczema area and severity index score) 1.) Erythema and inflammation (redness) 2.) Induration (thickness and swelling) 3.) Excoriation (scratching) 4.) Lichenification (thickened dry skin) 5.) Body surface area ```
222
Eczema management: mild
- Emollients - Soap substitutes - Intermittent topical steroids (risk of tachyphylaxis where skin gets used to steroid and steroid stops working) - Calcineurin inhibitors e.g. tacrolimus and pimercolimus
223
Eczema management: moderate
- Phototherapy (narrow band UVB or PUVA) | - Systemic immunosuppressive therapy (methotrexate, ciclosporin, azathioprine, mycophenolate)
224
Eczema management: severe
- Biological therapy (IL4/IL13 inhibitor = dupilumab)
225
Eczema management: flare ups
- Short course of oral steroid - Antibiotics oral for infected flares - For herpeticum – oral antivirals